{
    "clinical_study": {
        "@rank": "68989", 
        "arm_group": {
            "arm_group_label": "T3 > 4 nmol/l", 
            "description": "Acute hyperthyroidism with a T3 > 4 nmol/l"
        }, 
        "biospec_descr": {
            "textblock": "Serum and fat tissue"
        }, 
        "biospec_retention": "Samples With DNA", 
        "brief_summary": {
            "textblock": "The investigators wish to evaluate the effect of thyroid hormones on brown adipose tissue in\n      humans in an observational study on patients with thyrotoxicosis. In the investigators\n      evaluation the investigators will use FDG-PET/CT, indirect calorimetry and fat biopsies in\n      the acute phase of the disease and in the euthyroid phase after treatment.\n\n      It is the investigators hypothesis that high levels of circulating T3 might affect amount\n      and function of brown adipose tissue."
        }, 
        "brief_title": "Effects of Hyperthyroidism on Amount and Activity of Brown Adipose Tissue", 
        "completion_date": {
            "#text": "May 2016", 
            "@type": "Anticipated"
        }, 
        "condition": "Hyperthyroidism", 
        "condition_browse": {
            "mesh_term": "Hyperthyroidism"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  men and women with hyperthyroidism (T3 > 3 nmol/l)\n\n          -  > 50 years old\n\n          -  women must be postmenopausal\n\n        Exclusion Criteria:\n\n          -  thyrotoxic crises\n\n          -  severe concurrent sickness that will make it unsafe to postpone treatment, this\n             includes severe kidney disease (creatinin over 160)- and heart disease (NYHA group 3\n             and 4).\n\n          -  diabetes\n\n          -  former and current treatment with interleukin-2\n\n          -  Patients who are already treated with \u03b2-blockers\n\n          -  severe claustrophobia\n\n          -  BMI > 30 kg/m2"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "50 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "10 patients with hyperthyroidism, reffered to our hospital from their primary caretakers\n        will be investigated before and after 3 to 5 months in a proven euthyroid state."
            }
        }, 
        "enrollment": {
            "#text": "10", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "May 5, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02133040", 
            "org_study_id": "M-2013-236-13"
        }, 
        "is_fda_regulated": "No", 
        "keyword": "Brown Adipose Tissue", 
        "lastchanged_date": "May 6, 2014", 
        "location": {
            "contact": {
                "email": "peter.breining@ki.au.dk", 
                "last_name": "Peter Breining, MD", 
                "phone": "+45 78457163"
            }, 
            "contact_backup": {
                "email": "leneplag@rm.dk", 
                "last_name": "Lene Plagborg, Secretary", 
                "phone": "+45 7846 7696"
            }, 
            "facility": {
                "address": {
                    "city": "Aarhus", 
                    "country": "Denmark", 
                    "state": "Region Midtjylland", 
                    "zip": "8000"
                }, 
                "name": "Aarhus University Hospital"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Denmark"
        }, 
        "number_of_groups": "1", 
        "official_title": "Identification and Regulation of Brown Adipose Tissue (BAT) in Humans. Implications for Energy Expenditure in Humans and in the Treatment of Obesity and Related Metabolic Diseases", 
        "other_outcome": {
            "measure": "Changes in adrenergic receptor status and UCP1, PGC1alpha, PRDM16 and Dio2 levels in subcutaneous fat depots", 
            "safety_issue": "No", 
            "time_frame": "6 months"
        }, 
        "overall_contact": {
            "email": "peter.breining@ki.au.dk", 
            "last_name": "Peter Breining, MD", 
            "phone": "+45 78467163"
        }, 
        "overall_contact_backup": {
            "email": "bjoern.richelsen@aarhus.rm.dk", 
            "last_name": "Bj\u00f8rn Richelsen, Professor", 
            "phone": "+45 7846 7696"
        }, 
        "overall_official": {
            "affiliation": "University of Aarhus", 
            "last_name": "Bj\u00f8rn Richelsen, Professor", 
            "role": "Study Director"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": [
                "Denmark: Danish Dataprotection Agency", 
                "Denmark: Ethics Committee"
            ], 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "May 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Changes in Brown adipose tissue FDG uptake", 
            "measure": "FDG-PET/CT-scanning", 
            "safety_issue": "No", 
            "time_frame": "6 months"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02133040"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Aarhus University Hospital", 
            "investigator_full_name": "Peter Breining", 
            "investigator_title": "MD", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "description": "Changes in basal energy expenditure", 
            "measure": "Indirect Calorimetry", 
            "safety_issue": "No", 
            "time_frame": "6 months"
        }, 
        "source": "Aarhus University Hospital", 
        "sponsors": {
            "collaborator": {
                "agency": "Novo Nordisk A/S", 
                "agency_class": "Industry"
            }, 
            "lead_sponsor": {
                "agency": "Aarhus University Hospital", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "May 2014", 
        "study_design": "Observational Model: Case-Only, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "May 2014"
    }
}